Hector Crespo Soto, MD
Vascular Surgery · Charlotte, NCNPI 1750528758
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (34.1%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Kerecis Limited accounts for 84.0% of it on its own, with 27 other manufacturers making up the rest. Reporting peaked in 2022 at $71,939 and has fallen 53.9% since, to $33,183 in 2025. Among vascular surgery clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 288 payments — averaging $619.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kerecis Limited$150K
- Boston Scientific$4K
- Endologix LLC$4K
- Medtronic$4K
- Inari Medical, Inc.$3K
- Globus Medical$3K
- plus $11K from 22 others
Across 16 payments — averaging $2394.06 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- W. L. Gore & Associates, Inc.$22K
- Abbott$16K
- Inari Medical, Inc.$150
What the payments were for
- Consulting fees$60,75134%
- Speaking & faculty fees$55,70031%
- Travel & lodging$31,56618%
- Food & beverage$17,37810%
- Education$13,0027%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kerecis Limited | 64 | $149,840 |
| Boston Scientific | 48 | $4,369 |
| Endologix LLC | 23 | $4,186 |
| Medtronic(2 entities) | 61 | $3,901 |
| Inari Medical, Inc. | 6 | $2,693 |
| Globus Medical | 11 | $2,594 |
| Cardiovascular Systems Inc. | 8 | $2,438 |
| Penumbra, Inc. | 12 | $2,055 |
| KCI USA, Inc. | 1 | $850 |
| W. L. Gore & Associates, Inc. | 7 | $660 |
| Abbott | 7 | $612 |
| Silk Road Medical, Inc. | 4 | $477 |
| Cvrx, Inc. | 4 | $463 |
| Royal Biologics, Inc. | 1 | $457 |
| Bard Peripheral Vascular, Inc. | 3 | $438 |
| Cook Medical LLC | 4 | $430 |
| Merit Medical Systems Inc | 1 | $350 |
| Polynovo North America LLC | 4 | $278 |
| Philips North America LLC | 5 | $242 |
| Biom'up France SAS | 2 | $239 |
| Shockwave Medical, Inc | 5 | $201 |
| Terumo Medical Corporation | 1 | $160 |
| Stryker | 1 | $148 |
| Teleflex LLC | 1 | $144 |
| Janssen Scientific Affairs, LLC | 1 | $87 |
| Smith+Nephew | 1 | $36 |
| Davol Inc. | 1 | $33 |
| Johnson & Johnson | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis Omega3 Marigen$323,298
- Kerecis Omega3 SurgiClose$169,275
- Kerecis SurgiClose$112,739
- Kerecis Omega3 GraftGuide$98,515
- Kerecis GraftGuide$28,185
- Kerecis Omega3 Wound$5,158
- Kerecis Omega3 Surgibind$5,158
- Peripheral Orbital Atherectomy System$2,227
- ENDOCROSS Device$2,162
- Torus Stent Graft System$2,162
- ENDURANT IIS$2,087
- FLOWTRIEVER CATHETER, S$1,691
- CT THROMBECTOMY SYSTEM KIT$1,691
- ALIF$1,371
- Indigo$1,325
- FlowTriever$989
- ClotTriever$989
- AngioJet Ultra 5000A$950
- XLIF$872
- PREVENA$850
How this compares
$178,396 in reported general payments places this provider in the 95th percentile of 119 vascular surgery providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 32 | $25,563 |
| XareltoRivaroxaban | 13 | $12,396 |
| Cilostazol | 32 | $967 |
| ClopidogrelClopidogrel Bisulfate | 65 | $645 |
| Atorvastatin Calcium | 42 | $370 |
| Rosuvastatin Calcium | 20 | $263 |
| Ezetimibe | 12 | $173 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 22 | $131 |
| Methylprednisolone | 13 | $75 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $18 | $12,39613 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 119 vascular surgery providers in North Carolina.
Other vascular surgery in Charlotte
- Frank ArkoCharlotte$2.6M
- Erin MurphyCharlotte$598K
- Rebecca KelsoCharlotte$148K
- James AntezanaCharlotte$44K
- Peter FordCharlotte$18K
- Martin Lo SassoCharlotte$17K
- Tzvi NussbaumCharlotte$16K
- Daniel SprandoCharlotte$13K
- Adam StricklandCharlotte$3K
- Robert MendesRaleigh$408K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.